Nicorette Quickmist Smarttrack (Nicotine)

Nicotine delivered via Nicorette Quickmist Smarttrack is used in nicotine replacement therapy to support smoking cessation.

• Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms.
• Tobacco dependence: provides a controlled nicotine dose to facilitate gradual reduction of nicotine intake.
• Relapse prevention: supports maintenance of abstinence after quitting by mitigating occasional urges.

• Nicotine in the oral spray binds to nicotinic acetylcholine receptors in the brain, partially stimulating these receptors and releasing dopamine. This mimics the pharmacologic effects of tobacco‑derived nicotine, thereby decreasing the intensity of cravings and withdrawal symptoms while allowing the user to taper nicotine exposure over time.

Common Side Effects

• Throat irritation: mild soreness or burning sensation in the throat.
• Mouth dryness: reduced salivation leading to a dry feeling.
• Cough: transient coughing after spray administration.
• Nausea: occasional feeling of queasiness.
• Hiccups: brief episodes of involuntary diaphragm contraction.
• Taste disturbance: altered or metallic taste.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Dizziness: feeling light‑headed or unsteady.
• Increased heart rate: noticeable tachycardia.
• Chest pain: discomfort or pressure in the chest area.
• Severe mouth irritation: ulceration or persistent soreness.
• Nicotine poisoning: symptoms such as vomiting, confusion, or seizures.

Precautions should be observed when using Nicorette Quickmist Smarttrack.

• Pregnancy: safety not established; consult a healthcare professional before use.
• Breastfeeding: unknown effects; avoid unless advised by a clinician.
• Cardiovascular disease: use with caution and monitor for increased heart rate or blood pressure.
• Children and adolescents: not recommended for individuals under the legal smoking age.
• Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously.
• Store at room temperature: keep in the original container, protect from moisture and direct heat.

Potential drug interactions may affect the safety or efficacy of Nicorette Quickmist Smarttrack.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors: may increase hypertensive risk.
• Beta‑blockers: nicotine may mask tachycardia, complicating cardiovascular monitoring.
• Insulin: nicotine can alter glucose metabolism; monitor blood sugar closely.
• Alcohol: may enhance nicotine absorption and increase side‑effect potential.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs): observe for mood changes or increased anxiety.
• Caffeine: nicotine may potentiate stimulant effects, leading to jitteriness.